I. Introduction
The ovary is the second most common site for cancer in the female reproductive organs and is associated with the highest mortality rate. [1] The poor survival is due to the fact that they do not clinically manifest early and approximately 60-70% of the neoplasm present as either stage III or stage IV. [2] The emergence of tumors of low malignant potential has changed the prognosis of ovarian tumors and produce peritoneal nodules which may be mistaken for secondaries, should be differentiated by histopathology.
In spite of significant advances in imaging modalities, sometimes they are also misleading. Cytological interpretation of aspirates from ovary is most challenging and immunohistochemistry provides a functional correlation for the traditional morphological classification. Natural history and response to treatment vary considerably from one group of tumor to others, especially in the area of chemotherapy and radiotherapy. [3] Hence an accurate histology is often a critical factor in acheiving an optimum treatment response. As there are no screening tests or tumor markers, histopathology plays a key role in detection of ovarian cancer. In view of the above facts we have made an attempt for a detailed study of the morphological patterns of ovarian tumors and tried to correlate with other clinical details, hoping to obtain some meaningful relationship between incidence and distribution of various types of ovarian cancers, the ultimate goal being better management.
Aim of the study
The prospective and retrospective study of the ovarian neoplasms was undertaken to determine the prevalence, the age incidence and the morphologic variants of ovarian neoplasms.
II. Materials And Methods
A detailed retrospective and prospective study of 278 ovarian neoplasms was done from January 2002 to October 2008, taking into account relevant clinical data. In the retrospective study, the available H & E stained slides and available paraffin blocks of the ovarian tumors, in the department were studied from January 2002 to June 2006 and relative information were recorded from the biopsy records and statistical books. In the prospective study, the material comprised of excised surgical specimens of ovarian tumors from June 2006 to October 2008. Thorough grossing was done and multiple representative sections given. The tissue was processed by routine histological techniques and subjected for Haematoxylin & Eosin staining. Special stains like Mucicarmine, Vangeison's, Periodic acid Schiff and Reticulin stain were done whenever necessary Inclusion criteria: Both the primary & secondary histologically proven ovarian tumors were included.
Exclusion criteria:
Tumor like conditions were excluded in order to avoid confusion
III. Results
From the present study comprising the analysis of 3956 female genital tract neoplasms recorded from 2002 to 2008, the ovarian tumors accounted for 278, giving the incidence of 7.02%. Out of these 278 tumors 217 (78.05%) were benign & 61 (21.95%) were malignant, 275 were primary ovarian tumors (98.92%) and remaining 3 were secondary ovarian tumors (1.08%). The commonest presenting symptom was mass per abdomen followed by pain abdomen and menstrual disturbances for both benign and malignant tumors Primary Ovarian tumors were broadly divided into 3 categories based on WHO Classification as shown in TABLE 1.Out of 278 ovarian tumors 237 were surface epithelial tumors (85.25%), 11 were sex cord stromal tumors (3.95%), 27 were germ cell tumors (9.72%) and 3 were metastatic (1.08%).
Among surface epithelial tumors, serous type was highest (72.15%), followed by mucinous tumors (25.32%). In sex cord stromal tumors, granulosa cell is the most common malignant cell tumor and fibrothecoma (36.36%) constituted the predominant group among germ cell tumors. Out of 171 serous tumors, 141 were benign (82.46%), 3 were of low malignant potential (1.75%) and 27 were frankly malignant (15.79%). Out of 60 mucinous tumors, 47 were benign (78.33%), 2were tumors of low malignant potential (3.33%) and 11 were malignant (18.34%). Other epithelial tumors observed in the present study are clear cell carcinoma and Brenner tumor. It is well evident from the present study that sex cord stromal tumors are the least common among the primary ovarian tumors (3.95%). Granulosa cell tumor (36.36%) constituted the predominant tumor of this category. Out of 27 germ cell tumors, benign cystic teratoma were the commonest (66.67%) followed by dysgerminoma (18.53%). Out of 3 metastatic tumors observed (1.08%), 2 were from female genital tract and one was Krukenberg tumor as shown in TABLE 2.
Among total 278 ovarian tumors, benign were 217 (78.05%) and malignant 61 (21.95%). Out of 217 benign ovarian tumors, the serous tumors ranked first with a total of 141 (64.98% ) followed by mucinous comprising of 47 tumor (21.66%) & ranked third is benign cystic teratoma with a total of 18 (8.30%) as shown in TABLE 3.
Among 61 malignant ovarian tumors, serous carcinomas (borderline & invasive together) ranked first (49.18%) followed by mucinous carcinomas both borderline & invasive (21.30%) and third most common is dysgerminoma (8.20%) as depicted in TABLE 4 There were 15 bilateral ovarian tumors in the present study. Among the primary tumors, serous carcinomas were observed to be bilateral in a large number of cases (25.92%), followed by mucinous carcinomas (9.09%). Benign serous tumors were bilateral in only 3.54%. Among the secondary tumors, 2 out of 3 were bilateral with an incidence of 66.66% as shown in TABLE 5.
Among 278 ovarian tumors recorded the age of patients ranged from 13-82yr. The maximum cases of benign epithelial tumors were observed in 3 rd and 4 th decade of life with a peak in 4 th decade (32.26%). The type of benign tumor noted in the oldest patient of 82yr was mucinous cystadenoma. Most of the malignant ovarian neoplasms were found in between 41-60 years (27.86+27.32=49.18%). Germ cell tumors occurred relatively in a younger age group as compared to other malignant tumors. The secondary tumors were observed from 3 rd to 5 th decade of life as shown in TABLE 6.
IV. Discussion
The ovary is a complex structure from an embryological, anatomical and functional stand point. Therefore ovarian tumors aroused curiosity and problems to pathologists and clinicians regarding their abnormal contents and genesis. The value of detailed morphological study of ovarian tumors lies not only in systematic diagnosis but also in planning the modality of treatment and assessing the prognosis.
Surface epithelial tumors
In our study surface epithelial tumors (85.26%) constitute the most prominent type of ovarian tumors followed by germ cell tumors which is in agreement with other studies done by Misra.R.K. et al, Maheswari et al, Nasser A. Shaikh et al. [4, 5, 6] Benign serous tumors comprising 141 cases (50.72%) formed the largest group in the present study and our findings are identical to that of Misra R.K et al, but slightly higher than those of other authors Maheswari et al and Nasser A. Shaikh et al. This might be due to relative decrease in the occurrence of sex cord and germ cell tumors in our study. The incidence of borderline tumors in our study was 1.75% of total serous tumors, which is a lower figure when compared to 15% reported by Purola et al, Russel p et al. [7, 8] In the present study the serous carcinomas constituted 17.54% of all serous tumors. The findings of other authors are slightly lower than that of ours. In our study we observed psammoma bodies in 3 cases (10%) of serous malignant tumors. It was observed that the behavior of serious carcinomas with psammoma bodies resemble that of borderline tumors. [9] We used stromal invasion as criteria to distinguish borderline from serous carcinomas, the true invasion process is often associated with desmoplastic reaction and inflammatory response which are not seen in the invasion of borderline tumors. We have not come across any foci of microinvasion and peritoneal implants in our study, though they have been described by many authors in the western literature. [10] Second commonest group among all the ovarian tumors was of mucinous type consisting of 60 cases (21.52%) in the present study. Among these, the benign mucinous tumors formed 78.33%. Similar finding has been reported by Nasser. A. Shaikh et al, Misra R.K. et al Bennington, Kent & Mc kay. [4,6'11] The mucinous tumors are the largest with maximum size was 40x12x10cm, which is in accordance with other studies. Mucinous carcinomas formed 4.68% of all ovarian tumors which is almost similar to Misra. R.K. et al, Tandon et al & slightly lower than Maheswari et al & Nasser. A.Shaikh et al. [4, 5, 6 ,12} The occurrence of necrosis and hemorrhages were more common in invasive mucinous carcinomas than the borderline type. Microscopically when the invasion of the stroma is uncertain, the height of atypical epithelium has to be evaluated as suggested by Hart & Norris (1973) . If the height of atypical epithelium is 4 cells or greater the tumor is considered to be carcinoma. [13] We have one case of clear cell carcinoma in our study which is in close approximation with the incidence observed by others. This clear cell carcinoma has to be differentiated from dysgerminoma & metastatic renal cell carcinoma. Absence of lymphocytes and granulomas with positive PAS stain differentiates clear cell tumors from dysgerminomas. Renal cell carcinoma can be readily excluded by radiological studies & clinical data.
We have 2 cases of endometrioid adenocarcinoma with an incidence of 0.72% of all ovarian tumors which is slightly higher than the authors, but was equal to the findings of G.S.Pilli et al who observed 2 cases of endometrioid carcinoma comprising of 0.7% of total ovarian tumors. [14] In our study we had 2 cases of benign Brenner tumors (0.72%) among total ovarian tumors, comparatively higher than other studies. We observed one case of malignant Brenner tumor with an incidence of 0.35% of all ovarian tumors. This is almost similar to that of Maheswari et al. [5] Adjacent areas of typical benign Brenner was observed, which is an important criterion to differentiate from primary ovarian transitional carcinoma as suggested by Idelson (1963) , as the latter one is considered to have poorer prognosis. [15] Among the serum markers, CA-125 has been studied most extensively. Isolated values of CA-125 lack adequate sensitivity or specificity, but when monitored over time, serial CA-125 values can achieve a specificity of 99.6%. Multiple serum markers have been analyzed in women with early stage epithelial ovarian cancer. CA-125, CA 15-3, C19-9, CA 54-61, CA 72-4, CEA, TAG72, TNF, TPA, and UGTF have been studied alone and in combination. The serial measurement of complementary serum markers can improve the use of marker screening for epithelial ovarian cancer. [16, 17] 
Sexcord stromal tumors:
In our study we observed 11 cases of sex cord stromal tumors giving an incidence of 3.95%. Granulosa cell tumors and fibrotheoma are the most common variety of sex cord stromal tumors, which is lower than the observations made by other authors like Misra. R.K. et al (3.01%) and Nasser .A Shaikh et al (3.6%). Granulosa cell tumors constituted the majority of sex cord stromal tumors which is in accordance with that of Scully R.E. [18] We observed various patterns, but in our study the most common pattern is microfollicular type. Granulosa cell tumors should be differentiated from undifferentiated carcinoma, malignant lymphoma, small cell carcinoma & carcinoid by the presence of typical call exner bodies, coffee bean nuclei of granulosa cells & reticulin stain.
Though associated pathology like endometrial hyperplasia and endometrial carcinoma has been reported in 2-13% of patients, we have not come across any such association in our study. Juvenile granulosa cell tumor, Thecoma, Cellular fibromas & fibro sarcomas are not reported in our study. Combination of granulosa & theca cells, fibroma & thecoma were also seen in the present study which accounts for 1.08% & 1.43% of all ovarian tumors respectively. Similar observations were made by other studies.
Germ cell tumors:
Germ cell tumors constitute 15-20% of all ovarian tumors. In our study a total of 27 cases were observed (9.71%) which is slightly lower than the observations of other authors, but is almost similar to the findings of Nasser .A. Sheikh et al (10.67%). Dysgerminoma constitutes less than 1% of all ovarian tumors & about 5% of malignant ovarian tumors. In our study we observed 5 cases of dysgerminoma giving an incidence of 1.80% which is almost similar to the findings of other authors as Tandon Immature elements were excluded by careful examination and proper sampling because of its behavior as a malignant neoplasm.
Malignant transformation in a mature cystic teratoma is a rare occurrence. The reported incidence was 2.8% by Krumerman & Chung. [19] In our series also we had one case of moderately differentiated squamous cell carcinoma, giving the incidence of 5.26%, which is comparatively a higher figure. But the Indian authors like Tyagi et al documented this change in 4% (1 out of 25 cases). [20] This might be due to less number of benign cystic teratomas in the present work.
We had one case of immature teratoma giving an incidence of 1.36% of all ovarian tumors. Grading of these tumors into 0 to III types according to the degree of differentiation & quantity of mature tissue has been proposed by Thurlbeck & Scully & subsequently adopted with elaboration of the criteria by Norris H.J et al. [21, 22] In our case grade II differentiation was seen. The incidence of struma ovarii was found to be 0.36% of all the ovarian tumors in the present study. No evidence of thyrotoxicosis or malignancy was seen though such changes have been reported by others. We have not observed any case of mixed germ cell tumor in the present work.
Metastatic ovarian tumours:
Our study, showed 3 cases of secondary tumors (1.08%). Verma & Bhatia, reported a higher incidence of ovarian tumours (6.5%) where as Nasser A shaikh et al reported 1.58%. [23] Among the 3 cases only one case is Krukenberg with an incidence of 0.36% similar to that of other studies like Tandon et al & Misra R.K. et al, & remaining 2 were non krukenberg tumours (one is from adenocarcinoma endometrium and other from carcinoma cervix, each accounting for 0.36%).
Incidence of bilaterality:
In our study we observed 15 cases (5.40%) of bilateral tumors of which 5 were benign and 10 were malignant on both sides. Our findings were similar to Misra.R.K. et al 4.52%
V. Conclusions
The ovary is a very common site of neoplasia in the female genital tract. The ovarian tumors manifest a wide spectrum of clinical, morphological and histological features. As the natural history, treatment modalities and prognosis of ovarian neoplasms differ, the histomorphological study remains the gold standard. However, it may be supplemented by newer techniques like IHC, morphometirc analysis, cytometric analysis of ploidy status to resolve the difficult, dilemmatic cases and to predict prognosis. 
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